Treatment regimen | Effective | (%) |
ATRIPLA (TDF + FTC + EFV) | 29 | 58.9% |
TLD (TDF + 3TC + DTG) | 16 | 32.9% |
TDF + 3TC + EFV | 2 | 4.1% |
AZT + 3TC + Lopinavire/Ritonavir (Lpv/r) | 2 | 4.1% |
Total | 49 | 100% |